Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
The University of Texas Health Science Center at San Antonio
Grupo Espanol de Tumores Neuroendocrinos
Cancer Research UK
Universidad Nacional Autonoma de Mexico
Instituto do Cancer do Estado de São Paulo
Rigshospitalet, Denmark
British Columbia Cancer Agency
M.D. Anderson Cancer Center
Yale University
Vanderbilt-Ingram Cancer Center